Literature DB >> 33707849

Non Malignant Lymphoproliferative Disorders in Children: A Case Series.

Meena Sivasankaran1, Rishab Bharadwaj1, Somu Sivabalan2, Ravikumar Thangadorai2, Vimal Kumar1, Deenadayalan Munirathnam1.   

Abstract

Lymphoproliferative disorders occurs due to uncontrolled proliferation of lymphocytes that causes lymphocytosis, lymphadenopathy, and involvement of extra nodal sites (bone marrow, liver and spleen) and occur primarily due to immune dysfunction. We describe series of cases with non malignant LPD encountered in our practice and their varied clinical presentation, difficulties in diagnosis, underlying etiology, treatment and outcome. Many of these disorders are self limiting, however some are associated with significant morbidity, hence treatment must be tailored based on the underlying immune dysfunction and aggressiveness of the clone. © Indian Society of Hematology and Blood Transfusion 2020.

Entities:  

Keywords:  Immune dysregulation; Immunodeficiency; Lymphoproliferation

Year:  2020        PMID: 33707849      PMCID: PMC7900327          DOI: 10.1007/s12288-020-01323-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  13 in total

Review 1.  Spectrum of Phenotypes Associated with Mutations in LRBA.

Authors:  Omar K Alkhairy; Hassan Abolhassani; Nima Rezaei; Mingyan Fang; Kasper Krogh Andersen; Zahra Chavoshzadeh; Iraj Mohammadzadeh; Mariam A El-Rajab; Michel Massaad; Janet Chou; Asghar Aghamohammadi; Raif S Geha; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

2.  Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.

Authors:  K C Gilmour; T Cranston; A Jones; E G Davies; D Goldblatt; A Thrasher; C Kinnon; K E Nichols; H B Gaspar
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

3.  The clinical behavior of localized and multicentric Castleman disease.

Authors:  J Herrada; F Cabanillas; L Rice; J Manning; W Pugh
Journal:  Ann Intern Med       Date:  1998-04-15       Impact factor: 25.391

4.  XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.

Authors:  Stéphanie Rigaud; Marie-Claude Fondanèche; Nathalie Lambert; Benoit Pasquier; Véronique Mateo; Pauline Soulas; Lionel Galicier; Françoise Le Deist; Frédéric Rieux-Laucat; Patrick Revy; Alain Fischer; Geneviève de Saint Basile; Sylvain Latour
Journal:  Nature       Date:  2006-11-02       Impact factor: 49.962

5.  Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome.

Authors:  C A Sander; L J Medeiros; L M Weiss; T Yano; M C Sneller; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1992-12       Impact factor: 6.394

6.  Kikuchi disease and its association with systemic lupus erythematosus.

Authors:  K M el-Ramahi; A Karrar; M A Ali
Journal:  Lupus       Date:  1994-10       Impact factor: 2.911

Review 7.  Castleman disease.

Authors:  Anu Dham; Bruce A Peterson
Journal:  Curr Opin Hematol       Date:  2007-07       Impact factor: 3.284

8.  Successful treatment of lymphoproliferative disease complicating primary immunodeficiency/immunodysregulatory disorders with reduced-intensity allogeneic stem-cell transplantation.

Authors:  Jonathan M Cohen; Neil J Sebire; Julia Harvey; H Bobby Gaspar; Cale Cathy; Alison Jones; Kanchan Rao; David Cubitt; Persis J Amrolia; E Graham Davies; Paul Veys
Journal:  Blood       Date:  2007-05-14       Impact factor: 22.113

9.  Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

Authors:  C L Willman; L Busque; B B Griffith; B E Favara; K L McClain; M H Duncan; D G Gilliland
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

Review 10.  Kikuchi-Fujimoto disease.

Authors:  Xavier Bosch; Antonio Guilabert
Journal:  Orphanet J Rare Dis       Date:  2006-05-23       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.